Genetic research has been instrumental in developing leading methods used to understand the nature and scope of cancer syndromes. With improved cancer diagnosis and targeted therapies for treatment, the discovery of changes in genes and their expression characteristics will continue to advance as a field.
Study the signaling pathways of common and rare genetic mutations involved in cancer. This course will expose you to the cutting-edge research that offers attractive development for new anti-cancer drugs and therapeutic strategies. From the differences between sporadic and familial cancers to systemic and targeted level treatment studies, you will learn the history of cancer and how it shaped society and research today.
You Will Learn
Current methods involved in cancer research
Differences between multiple classes of genetic mutations
Progressions of tumorigenesis in minor genome changes
Targeted therapies for the latest cancer treatments
Laura Attardi, Professor Of Radiation Oncology and of Genetics
Emily Crane, Instructor, Stanford University
Joe Lipsick, Professor of Pathology, Genetics and, by courtesy, Stanford University
Julien Sage, Associate Professor of Pediatrics (Cancer Biology), Stanford University
Ruth Tennen, Lecturer, Stanford University
Monte Winslow, Assistant Professor of Genetics and of Pathology, Stanford University
Stacey Wirt Taylor, Lecturer, Stanford University
*This certificate neither substitutes for, nor leads to, being board certified as a genetic counselor (ABGC) or clinical geneticist (ABMG)